Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited announced a change in the director’s interest, with Gerard Dalbosco acquiring 7,442 ordinary shares, bringing his total to 27,442 shares. This transaction, valued at $32,372.70, reflects continued confidence in the company’s market position and potential growth, potentially impacting stakeholders’ perception positively.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products designed to reduce the risk of infection transmission in healthcare settings.
YTD Price Performance: 48.40%
Average Trading Volume: 833
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $836.9M
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.